- Home
- EXEL vs LCID Comparison
EXEL vs LCID Comparison
Compare EXEL & LCID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- LCID
- Stock Information
- Founded
- EXEL 1994
- LCID 2007
- Country
- EXEL United States
- LCID United States
- Employees
- EXEL N/A
- LCID N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- LCID Auto Manufacturing
- Sector
- EXEL Health Care
- LCID Consumer Discretionary
- Exchange
- EXEL Nasdaq
- LCID Nasdaq
- Market Cap
- EXEL 9.7B
- LCID 9.0B
- IPO Year
- EXEL 2000
- LCID N/A
- Fundamental
- Price
- EXEL $36.20
- LCID $3.07
- Analyst Decision
- EXEL Buy
- LCID Hold
- Analyst Count
- EXEL 17
- LCID 9
- Target Price
- EXEL $35.50
- LCID $3.18
- AVG Volume (30 Days)
- EXEL 2.5M
- LCID 100.5M
- Earning Date
- EXEL 02-04-2025
- LCID 02-25-2025
- Dividend Yield
- EXEL N/A
- LCID N/A
- EPS Growth
- EXEL 441.02
- LCID N/A
- EPS
- EXEL 1.55
- LCID N/A
- Revenue
- EXEL $2,081,598,000.00
- LCID $730,510,000.00
- Revenue This Year
- EXEL $20.53
- LCID $33.01
- Revenue Next Year
- EXEL $0.95
- LCID $84.40
- P/E Ratio
- EXEL $23.39
- LCID N/A
- Revenue Growth
- EXEL 17.31
- LCID 4.98
- 52 Week Low
- EXEL $20.02
- LCID $1.93
- 52 Week High
- EXEL $37.59
- LCID $4.43
- Technical
- Relative Strength Index (RSI)
- EXEL 58.54
- LCID 56.69
- Support Level
- EXEL $33.05
- LCID $2.85
- Resistance Level
- EXEL $37.59
- LCID $3.16
- Average True Range (ATR)
- EXEL 0.99
- LCID 0.26
- MACD
- EXEL 0.28
- LCID -0.03
- Stochastic Oscillator
- EXEL 69.38
- LCID 27.85
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About LCID Lucid Group Inc.
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.